Subcutaneous vs IV formulations

Talk, we turn our attention to subcutaneous versus IV formulations, framing our discussion around the fundamental differences between subcutaneous and intravenous drug formulations, including their administration methods, pharmacokinetics and impact on patient experience. We will analyze the unique challenges and advances related to each route, particularly in formulation development and clinical outcomes. Decision making factors such as clinical indications, patient preferences, and practical considerations will also be discussed, all aimed at optimizing efficacy, safety and quality of life. These two administration routes are essential in therapeutic practice, but are not interchangeable. Understanding their differences in administration, pharmacokinetics, patient experience, formulation development, and clinical outcomes is crucial. In this session, we examine key distinctions, challenges, and recent advances, offering information that helps clinicians and scientists make informed decisions to enhance efficacy, safety, and patient quality of life. Let's begin by contrasting the basic administration routes for subcutaneous and intravenous drug formulations. Intravenous or IV formulations are introduced directly into systemic circulation, typically through a vein by infusion or bolus, requiring trained staff and sterile conditions, but allowing immediate drug availability. In contrast, subcutaneous or SC,